{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:30:45Z","timestamp":1781548245551,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.ygyno.2012.11.012","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T00:30:29Z","timestamp":1353025829000},"page":"288-293","source":"Crossref","is-referenced-by-count":55,"title":["Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer"],"prefix":"10.1016","volume":"128","author":[{"given":"Michael R.","family":"Folkert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin K.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa A.","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Makker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaled M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.11.012_bb0005","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.6004\/jnccn.2010.0106","article-title":"The emerging use of IMRT for treatment of cervical cancer","volume":"8","author":"Loiselle","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cncr.21284","article-title":"Intensity-modulated radiation therapy use in the U.S., 2004","volume":"104","author":"Mell","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cncr.11489","article-title":"A survey of intensity-modulated radiation therapy use in the United States","volume":"98","author":"Mell","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0020","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0025","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","article-title":"Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies","volume":"52","author":"Mundt","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0030","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","article-title":"Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy","volume":"56","author":"Mundt","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","article-title":"Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0045","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","article-title":"Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies","volume":"48","author":"Roeske","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PPO.0b013e318173a04b","article-title":"Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients","volume":"14","author":"Chen","year":"2008","journal-title":"Cancer J"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0055","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.04.041","article-title":"Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix","volume":"80","author":"Hasselle","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0065","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0070","unstructured":"RTOG 0418. A phase II study of intensity modulated radiation therapy (IMRT) to the pelvis \u00b1 chemotherapy for post-operative patients with either endometrial or cervical carcinoma."},{"key":"10.1016\/j.ygyno.2012.11.012_bb0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Statist Assoc"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Statist Assoc"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10147-010-0171-5","article-title":"Risk factors for lower-limb lymphedema after surgery for cervical cancer","volume":"16","author":"Ohba","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0360-3016(03)00521-2","article-title":"Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy","volume":"57","author":"Lujan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0105","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.ijrobp.2010.07.307","article-title":"Hematologic toxicity on RTOG 0418: a phase II study of post-operative IMRT for gynecologic cancer","volume":"78","author":"Klopp","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0110","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2006.11.005","article-title":"Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy","volume":"67","author":"Chen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.11.012_bb0115","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2011.06.007","article-title":"A phase II multi-institutional study of postoperative pelvic intensity modulated radiation therapy (IMRT) with weekly cisplatin in patients with cervical carcinoma: two year efficacy results of the RTOG 0418","volume":"81","author":"Portelance","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812008785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T10:20:14Z","timestamp":1540117214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812008785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0090825812008785"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.11.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}